|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT01365351 |
|
Date of registration:
|
01/06/2011 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
|
|
Scientific title:
|
Non-interventional Study With ZOMACTON in Children With Growth Hormone Deficiency |
|
Date of first enrolment:
|
December 1, 2007 |
|
Target sample size:
|
1034 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01365351 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Clinical Development Support |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Ferring Pharmaceuticals |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- therapeutic need according to SPC
- written informed consent
Exclusion Criteria:
- contraindications according to SPC
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Growth Hormone Deficiency
|
|
Intervention(s)
|
|
Other: Growth hormone
|
|
Primary Outcome(s)
|
|
Efficacy of ZOMACTON
[Time Frame: Up to 5 years]
|
|
Secondary Outcome(s)
|
|
Efficacy measured by further parameters
[Time Frame: Up to 5 years]
|
|
Safety of Zomacton and application device
[Time Frame: Up to 5 years]
|
|
Secondary ID(s)
|
|
ZOM/011207/03
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|